Universal Ibogaine Stock Performance

IBOGF Stock  USD 0.01  0.0005  8.33%   
Universal Ibogaine holds a performance score of 9 on a scale of zero to a hundred. The entity has a beta of -3.64, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Universal Ibogaine are expected to decrease by larger amounts. On the other hand, during market turmoil, Universal Ibogaine is expected to outperform it. Use Universal Ibogaine jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to analyze future returns on Universal Ibogaine.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Universal Ibogaine are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Universal Ibogaine reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow2.2 M
Total Cashflows From Investing Activities-2.1 M
Free Cash Flow-4.4 M
  

Universal Ibogaine Relative Risk vs. Return Landscape

If you would invest  0.50  in Universal Ibogaine on November 5, 2025 and sell it today you would earn a total of  0.05  from holding Universal Ibogaine or generate 10.0% return on investment over 90 days. Universal Ibogaine is currently producing 2.7415% returns and takes up 23.0755% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Universal, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Universal Ibogaine is expected to generate 30.41 times more return on investment than the market. However, the company is 30.41 times more volatile than its market benchmark. It trades about 0.12 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.1 per unit of risk.

Universal Ibogaine Target Price Odds to finish over Current Price

The tendency of Universal Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.01 90 days 0.01 
about 51.52
Based on a normal probability distribution, the odds of Universal Ibogaine to move above the current price in 90 days from now is about 51.52 (This Universal Ibogaine probability density function shows the probability of Universal Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Universal Ibogaine has a beta of -3.64. This usually indicates as returns on its benchmark rise, returns on holding Universal Ibogaine are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Universal Ibogaine is expected to outperform its benchmark. In addition to that Universal Ibogaine has an alpha of 2.277, implying that it can generate a 2.28 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Universal Ibogaine Price Density   
       Price  

Predictive Modules for Universal Ibogaine

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Universal Ibogaine. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.0123.03
Details
Intrinsic
Valuation
LowRealHigh
0.00023.02
Details
Naive
Forecast
LowNextHigh
0.00010.0123.02
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
000.01
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Universal Ibogaine. Your research has to be compared to or analyzed against Universal Ibogaine's peers to derive any actionable benefits. When done correctly, Universal Ibogaine's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Universal Ibogaine.

Universal Ibogaine Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Universal Ibogaine is not an exception. The market had few large corrections towards the Universal Ibogaine's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Universal Ibogaine, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Universal Ibogaine within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
2.28
β
Beta against Dow Jones-3.64
σ
Overall volatility
0
Ir
Information ratio 0.09

Universal Ibogaine Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Universal Ibogaine for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Universal Ibogaine can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Universal Ibogaine is way too risky over 90 days horizon
Universal Ibogaine has some characteristics of a very speculative penny stock
Universal Ibogaine appears to be risky and price may revert if volatility continues
Universal Ibogaine has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 1.07 M. Net Loss for the year was (10.5 M) with profit before overhead, payroll, taxes, and interest of 497.15 K.
Universal Ibogaine has accumulated about 1.95 M in cash with (4.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Universal Ibogaine Fundamentals Growth

Universal Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Universal Ibogaine, and Universal Ibogaine fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Universal Pink Sheet performance.

About Universal Ibogaine Performance

By analyzing Universal Ibogaine's fundamental ratios, stakeholders can gain valuable insights into Universal Ibogaine's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Universal Ibogaine has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Universal Ibogaine has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine is traded on OTC Exchange in the United States.

Things to note about Universal Ibogaine performance evaluation

Checking the ongoing alerts about Universal Ibogaine for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Universal Ibogaine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Universal Ibogaine is way too risky over 90 days horizon
Universal Ibogaine has some characteristics of a very speculative penny stock
Universal Ibogaine appears to be risky and price may revert if volatility continues
Universal Ibogaine has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 1.07 M. Net Loss for the year was (10.5 M) with profit before overhead, payroll, taxes, and interest of 497.15 K.
Universal Ibogaine has accumulated about 1.95 M in cash with (4.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating Universal Ibogaine's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Universal Ibogaine's pink sheet performance include:
  • Analyzing Universal Ibogaine's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Universal Ibogaine's stock is overvalued or undervalued compared to its peers.
  • Examining Universal Ibogaine's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Universal Ibogaine's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Universal Ibogaine's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Universal Ibogaine's pink sheet. These opinions can provide insight into Universal Ibogaine's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Universal Ibogaine's pink sheet performance is not an exact science, and many factors can impact Universal Ibogaine's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Universal Pink Sheet analysis

When running Universal Ibogaine's price analysis, check to measure Universal Ibogaine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universal Ibogaine is operating at the current time. Most of Universal Ibogaine's value examination focuses on studying past and present price action to predict the probability of Universal Ibogaine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universal Ibogaine's price. Additionally, you may evaluate how the addition of Universal Ibogaine to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Share Portfolio
Track or share privately all of your investments from the convenience of any device